Two Sigma Securities, LLC Bausch Health Companies Inc. Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $66,935 - $114,228	10,973 New	10,973 $76,000
Q4 2022 Feb 14, 2023	BUY	$6.09 - $7.93 $130,569 - $170,019	21,440 New	21,440 $134,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $927,525 - $1.19 Million	42,941 New	42,941 $981,000
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $284,027 - $358,244	-12,349 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1,126 - $1,352	45 Added 0.37%	12,349 $344,000
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $18,432 - $21,974	672 Added 5.78%	12,304 $361,000
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $173,084 - $234,152	11,632 New	11,632 $181,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $275,743 - $424,905	-20,717 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $133,174 - $310,365	10,260 Added 98.12%	20,717 $321,000
Q3 2019 Nov 14, 2019	SELL	$20.88 - $25.66 $486,608 - $598,006	-23,305 Reduced 69.03%	10,457 $228,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $595,561 - $956,139	33,762 New	33,762 $624,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.77B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.